We are live on ! Find out more
LVACU

LAVA Medtech Acquisition Corp. Unit

Delisted

LVACU was delisted on the 19th of April, 2023.

11 hedge funds and large institutions have $11.1M invested in LAVA Medtech Acquisition Corp. Unit in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less capital invested

Capital invested by funds: $11.7M → $11.1M (-$676K)

21% less funds holding

Funds holding: 1411 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
11
Holders Change
-3
Holders Change %
-21.43%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

LVACU Hedge Fund Activity: Q3 2022 in Review

11 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Unit (LVACU) for Q3 2022, worth a combined $11.1M — down 5.8% from $11.7M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of LVACU and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Schonfeld Strategic Advisors, cutting an estimated $403K.

  • 11 institutional investors held LAVA Medtech Acquisition Corp. Unit (LVACU) as of Q3 2022, down from 14 in Q2 2022.
  • Funds reported $11.1M of LAVA Medtech Acquisition Corp. Unit stock for Q3 2022, down 5.8% quarter-over-quarter.
  • 0 funds opened new LAVA Medtech Acquisition Corp. Unit positions in Q3 2022 and 3 closed out, a net change of -3 holders.
  • The largest LAVA Medtech Acquisition Corp. Unit seller in Q3 2022 was Schonfeld Strategic Advisors, an estimated $403K sold.

Based on aggregated 13F filings for Q3 2022.